Exercise induced asthma

Jump to navigation Jump to search
Exercise induced asthma
ICD-9 493.81
DiseasesDB 31728
MeSH D001250

Asthma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Asthma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Pulmonary Function Test
Bronchial Challenge Test
Exhaled nitric oxide

Treatment

Emergency Management

Medical Therapy

Alternative and Complementary Medicine

Bronchial Thermoplasty

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Exercise induced asthma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Exercise induced asthma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Exercise induced asthma

CDC on Exercise induced asthma

Exercise induced asthma in the news

Blogs on Exercise induced asthma

Directions to Hospitals Treating Asthma

Risk calculators and risk factors for Exercise induced asthma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Overview

Exercise-induced asthma, or E.I.A., is a medical condition characterized by shortness of breath induced by sustained aerobic exercise. In patients with bronchial hyperresponsiveness, vigorous physical activity triggers acute narrowing of the airways. E.I.A. shares many features with other types of asthma, and responds to some typical asthmatic medications, but does not appear to be caused by the same inflammatory reaction as the other types.

Pathophysiology

Triggering Factors

  • Exposure to cold or dry air
  • Environmental allergens
  • Bronchial hyperresonsiveness
  • Increased duration and intensity of exercise
  • Concomitant viral infection

Pathogenesis

The underlying pathogenesis for E.I.A. is poorly understood. E.I.A usually occurs after at least several minutes of vigorous, aerobic activity, which demands supplementation of normal nasal breathing with mouth breathing. The resultant inhalation of air is neither warmed to bod temperature or humidified by the nasal passages; hence, seems to generate increased blood flow to the linings of the bronchial tree, resulting in edema and subsequent constriction of these bronchial vessels, worsening the degree of obstruction to airflow. This sequence generates symptoms similar to those seen in other forms of asthma, but occurs without the inflammatory changes that underlie them.

Diagnosis

History and Symptoms

During an attack, the E.I.A. victim will likely be short of breath and/or coughing, with an elevated respiratory rate and wheezing, which may be audible even without a stethoscope. Examination will usually reveal the wheezing and a prolonged expiratory phase. In the occasional severe attack, altered level of consciousness and cyanosis due to depressed oxygenation of the blood may occur. Severe attacks are often the result of someone with both allergic and exercise-induced asthma exercising in a high-allergen environment (e.g. walking uphill alongside slowly moving traffic at dusk), and can be fatal.

In most cases, a relative "refractory period" follows resolution of an attack. During this approximately one hour period, resumption of exercise will likely produce either none or mild symptoms. Curiously as well, some 6-10 hours after the initial attack, a rebound attack with milder symptoms often develops without precipitating exertion.

Treatment

As with any asthma, the best treatment is avoidance, when possible, of conditions predisposing to attacks. In athletes who wish to continue their sport, and/or do so at times in adverse conditions, preventive measures, including altered training techniques and medications, can be taken.

Some athletes take advantage of the refractory period by precipitating an attack by "warming up," and then timing their competition such that it occurs during the refractory period. Step-wise training works in a similar fashion. An athlete warms up in stages of increasing intensity, using the refractory period generated by each stage to get up to a full workload.

The most common medication approach is to use a beta agonist about twenty minutes before exercise. Some physicians prescribe inhaled anti-inflammatory mists such as corticosteroids or leukotriene antagonists, and mast cell stabilizers have also proven effective. A randomized crossover study compared oral montelukast with inhaled salmeterol, both given two hours before exercise. Both drugs had similar benefit but montelukast lasted 24 hours.[1]

Prognosis

As evidenced by the many professional athletes who have overcome E.I.A. using some combination of the above treatments, the prognosis is usually very good. Olympic swimmers Tom Dolan, Amy Van Dyken, and Nancy Hogshead, baseball Hall of Famer Catfish Hunter, and American football player Jerome Bettis are among the many who have done so.

At the same time, it should be noted that according to International Olympic Committee statistics, during most of Olympic Games in last 20 years from 1/3 to 2/3 of athletes claimed to have asthma. Some medical experts tie such inordinate rates of reported asthma with athletes' desire to use complex medication to help them achieve better results.

References

  1. Philip G, Pearlman DS, Villarán C; et al. (2007). "Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction". Chest. 132 (3): 875–83. doi:10.1378/chest.07-0550. PMID 17573489.

Template:WH Template:WS